Boutet Emilie, El Mourabit Haquima, Prot Matthieu, Nemani Mona, Khallouf Eliane, Colard Odile, Maurice Michèle, Durand-Schneider Anne-Marie, Chrétien Yves, Grès Sandra, Wolf Claude, Saulnier-Blache Jean-Sébastien, Capeau Jacqueline, Magré Jocelyne
INSERM, UMR, CDR Saint-Antoine, Paris, France.
Biochimie. 2009 Jun;91(6):796-803. doi: 10.1016/j.biochi.2009.01.011. Epub 2009 Feb 6.
Berardinelli-Seip congenital lipodystrophy (BSCL) is a rare recessive disease characterized by near absence of adipose tissue and severe insulin resistance. In most cases, BSCL is due to loss-of-function mutations in the genes encoding either seipin of unknown function or 1-acyl-glycerol-3-phosphate O-acyltransferase 2 (AGPAT2) which catalyses the formation of phosphatidic acid from lysophosphatidic acid. We studied the lipid profile of lymphoblastoid cell-lines from 20 BSCL patients with null mutations in the genes encoding either seipin (n=12) or AGPAT2 (n=8) in comparison to nine control cell-lines. In seipin deficient cells, we observed alterations in the pattern of lipid droplets which were decreased in size and increased in number as compared to control cells. We also observed alterations in the triglycerides content as well as in the fatty acid composition from triglycerides and phosphatidylethanolamine, with an increased proportion of saturated fatty acids at the expense of the corresponding monounsaturated fatty acids, reflecting a defect in Delta9-desaturase activity. In AGPAT2 deficient cells, no specific alterations in lipid droplet pattern nor in fatty acid composition was observed but the cellular level of lysophosphatidic acid was increased as compared to that of control and seipin deficient cells. These results indicate that seipin like AGPAT2 is involved in lipid metabolism but exerts a different function. Seipin intervenes at a proximal step in triglycerides and phospholipids biosynthesis being involved in the pathway that links fatty acid Delta9 desaturation to lipid droplet formation. These findings provide new insights into how seipin deficiency causes severe lipodystrophy.
贝拉尔迪内利 - 塞普先天性脂肪营养不良(BSCL)是一种罕见的隐性疾病,其特征是几乎没有脂肪组织且存在严重的胰岛素抵抗。在大多数情况下,BSCL是由于编码功能未知的丝氨酸蛋白酶抑制剂(seipin)或1 - 酰基甘油 - 3 - 磷酸O - 酰基转移酶2(AGPAT2)的基因发生功能丧失突变所致,AGPAT2可催化溶血磷脂酸形成磷脂酸。我们研究了20例BSCL患者淋巴母细胞系的脂质谱,这些患者在编码seipin(n = 12)或AGPAT2(n = 8)的基因中存在无效突变,并与9个对照细胞系进行了比较。在seipin缺陷细胞中,我们观察到脂滴模式发生改变,与对照细胞相比,脂滴尺寸减小且数量增加。我们还观察到甘油三酯含量以及甘油三酯和磷脂酰乙醇胺的脂肪酸组成发生改变,饱和脂肪酸比例增加,相应的单不饱和脂肪酸比例降低,这反映了Δ9 -去饱和酶活性存在缺陷。在AGPAT2缺陷细胞中,未观察到脂滴模式或脂肪酸组成有特异性改变,但与对照细胞和seipin缺陷细胞相比,溶血磷脂酸的细胞水平升高。这些结果表明,seipin与AGPAT2一样参与脂质代谢,但发挥不同功能。Seipin在甘油三酯和磷脂生物合成的近端步骤发挥作用,参与将脂肪酸Δ9去饱和与脂滴形成联系起来的途径。这些发现为seipin缺乏导致严重脂肪营养不良提供了新的见解。